(ROIV) Roivant Sciences - Performance -7.7% in 12m
Compare ROIV with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
12.87%
#31 in Group
Rel. Strength
36.34%
#4864 in Universe
Total Return 12m
-7.69%
#49 in Group
Total Return 5y
-3.08%
#42 in Group
P/E -
(unknown) Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -24.56%
(unknown) Percentile in Group
12m Total Return: ROIV (-7.7%) vs XBI (-11%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
| LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
| BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
| KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: ROIV vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ROIV
| Total Return (including Dividends) | ROIV | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -0.88% | -5.85% | -3.01% |
| 3 Months | -16.56% | -11.95% | -3.15% |
| 12 Months | -7.69% | -11.00% | 10.19% |
| 5 Years | -3.08% | 0.65% | 129.24% |
| Trend Score (consistency of price movement) | ROIV | XBI | S&P 500 |
| 1 Month | -38.8% | -59.8% | -5.5% |
| 3 Months | -71.5% | -70.5% | -58.4% |
| 12 Months | -1.40% | -6.9% | 84.1% |
| 5 Years | 54.5% | -50% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #54 | 5.27% | 2.19% |
| 3 Month | #67 | -5.23% | -13.8% |
| 12 Month | #48 | 3.71% | -16.2% |
| 5 Years | #28 | 68.0% | -40.4% |
FAQs
Does ROIV Roivant Sciences outperforms the market?
Yes,
over the last 12 months ROIV made -7.69%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months ROIV made -16.56%, while XBI made -11.95%.
Over the last 3 months ROIV made -16.56%, while XBI made -11.95%.
Performance Comparison ROIV vs Indeces and Sectors
ROIV vs. Indices ROIV is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.73% | 2.13% | -10.5% | -17.9% |
| US NASDAQ 100 | QQQ | -1.75% | 3.18% | -9.74% | -16.3% |
| US Dow Jones Industrial 30 | DIA | -2.93% | 1.26% | -11.4% | -17.2% |
| German DAX 40 | DAX | -1.43% | 2.50% | -27.3% | -29.4% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.44% | -1.11% | 4.72% | -16.8% |
| Hongkong Hang Seng | HSI | -4.70% | -3.65% | -1.29% | -25.0% |
| India NIFTY 50 | INDA | -3.76% | -8.75% | -0.16% | -8.39% |
| Brasil Bovespa | EWZ | -2.84% | -9.17% | -2.51% | 4.05% |
ROIV vs. Sectors ROIV is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.19% | 2.93% | -18.6% | -26.9% |
| Consumer Discretionary | XLY | -3.49% | 2.95% | -13.9% | -21.8% |
| Consumer Staples | XLP | -5.52% | 0.96% | -11.4% | -18.7% |
| Energy | XLE | -3.82% | -8.90% | -16.1% | -8.50% |
| Financial | XLF | -3.21% | 1.82% | -22.7% | -29.9% |
| Health Care | XLV | -3.15% | 2.28% | -5.81% | -9.38% |
| Industrial | XLI | -3.04% | -0.19% | -9.80% | -16.2% |
| Materials | XLB | -3.83% | -1.39% | -2.40% | -3.75% |
| Real Estate | XLRE | -4.77% | 1.81% | -7.39% | -21.1% |
| Technology | XLK | -1.60% | 3.13% | -5.39% | -9.70% |
| Utilities | XLU | -6.02% | -1.70% | -9.63% | -32.9% |
| Aerospace & Defense | XAR | -2.13% | -2.16% | -14.4% | -28.6% |
| Biotech | XBI | 1.83% | 4.97% | 7.19% | 3.31% |
| Homebuilder | XHB | -3.23% | -1.03% | 8.87% | 0.01% |
| Retail | XRT | -5.03% | -0.38% | -6.43% | -2.90% |